ArticleNucleic acids research2025
A-to-I mRNA editing in bacteria can affect protein sequence, disulfide bond formation, and function.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Compendium of RNA modifications for bacterial stress adaptation.Microbiology and molecular biology reviews : MMBR · 2026Review
- EndoV does not measurably affect TadA-dependent A-to-I RNA editing inMicrobiology spectrum · 2026Article
- Article
- The Landscape and Regulatory Determinants of A-to-I RNA Editing in Escherichia coli and Pseudomonas aeruginosa Isolated From Patients With Urinary Tract and Ear Infections.The Journal of infectious diseases · 2026Article
- Evolution of Engineered ADAR-Based RNA Editing Systems.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Adenosine-to-inosine (A-to-I) mRNA editing can alter genetic information at the RNA level and is known to affect protein sequence and function in eukaryotes. However, the ability of A-to-I mRNA editing to recode protein sequences in bacteria was never shown at the protein level. Furthermore, the effect of A-to-I mRNA editing itself-not by A-to-G DNA-mimicking mutations-on protein function was never demonstrated in bacteria. Here, we show at the RNA and protein levels that A-to-I mRNA editing directly recodes a tyrosine to a cysteine residue in the toxin HokB (part of the HokB/sokB toxin-antitoxin system in Escherichia coli). Consequently, the toxicity of edited HokB increases, inducing bacterial death or early entrance into the stationary phase, depending on its expression level. Furthermore, we demonstrate that in vivo disulfide bond formation underlies the effect of A-to-I mRNA editing on HokB function, suggesting that A-to-I mRNA editing constitutes a novel mechanism to regulate disulfide bond formation in bacteria. Finally, we observe that A-to-I mRNA editing of hokB is conserved in pathogenic bacteria, supporting functional importance with possible clinical relevance. Our work reveals that A-to-I mRNA editing can constitute a novel mechanism to regulate protein sequence, disulfide bonds, and function in bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.